Recombinant IL-22 promotes protection in a murine model of Aspergillus flavus keratitis and mediates host immune responses in human corneal epithelial cells.
Mallela. Lakshmi Sruthi LS; Sharma. Prerana P; Rao. Tata Santosh RamaBhadra TSR; Roy. Sanhita S
Key Findings
- Patients with fungal keratitis and infected mice show higher levels of the antimicrobial peptide LL‑37 and the cytokine IL‑22.
- IL‑22 activates immune signaling pathways (NF‑κB, MAPK, STAT3) in corneal epithelial cells and boosts production of antimicrobial peptides.
- Recombinant IL‑22 reduces fungal load and corneal cloudiness in a mouse model, and protects eye cells from death in vitro.
Practical Outcomes
- For biohackers, the main takeaway is that IL‑22 shows promise as a targeted treatment for fungal eye infections, but it is not a readily usable supplement or protocol for general health, longevity, or performance. More research is needed before any at‑home application could be considered.
Summary
The study looked at eye infections caused by a fungus and found that a protein called IL‑22 can help protect eye cells and reduce the infection in mice. It also noted that another natural antimicrobial peptide, LL‑37, is higher in infected human eyes, but the research does not give any direct ways to use these findings for everyday health or longevity.
Abstract
Aspergillus flavus is a leading cause of corneal infections in India and worldwide, resulting in severe visual impairment. We studied the host immune response towards A. flavus in immortalised human corneal epithelial cells (HCEC) and found increased expression of Toll-like receptors, antimicrobial peptides and proinflammatory cytokines like IL-6 and IL-8. Differential expressions of antimicrobial peptides were determined in corneal scrapings from A. flavus keratitis patients with significantly increased expression of LL-37, S100A12 and RNase 7. Increased levels of IL-22 expression were observed both in patients with A. flavus keratitis and in experimental mice model of corneal infections along with IL-17, IL-23 and IL-18. IL-22 is an important mediator of inflammation during microbial infections, and acts primarily on fibroblasts and epithelial cells. We observed constitutive expression of IL-22 receptors in HCEC, and IL-22 mediated activation of NF-κB, MAPK pathways and STAT3, along with increased expression of antimicrobial peptides in these cells. IL-22 also efficiently lessened cell deaths in corneal epithelial cells during A. flavus infection in vitro. Furthermore, recombinant IL-22 reduced fungal burden and corneal opacity in an experimental murine model of A. flavus keratitis.
Study Information
pubmed
2021
2021-06-03T00:00:00.000Z
10.1111/cmi.13367
11
62